S100A7, for example, is implicated in inflammatory skin diseases and in several cancers including breast cancer [4,10-13] where it is associated with aggressive estrogen receptor negative tumors and poor prognosis [14,15]. Here, S100A7 is linked to inflammatory skin disease.